FDA Expands Meningitis Investigation

By: Associated Press
By: Associated Press
Other illnesses have been traced back to products from New England Compounding Center.

This undated image made available by The Centers for Disease Control and Prevention shows the Exserohilum rostratum fungus. (AP Photo/CDC)

Health officials have broadened their warning to doctors about other medicines made by a specialty pharmacy linked to a meningitis outbreak.
The Food and Drug Administration took the step Monday because of reports of new illnesses that may be tied to other products made by the same company, the New England Compounding Center of Framingham, Mass.
Now health officials want doctors to contact patients who got any injection made by the company and warn them of the risk of infection.
A steroid made by the pharmacy has been tied to a national outbreak of a rare fungal form of meningitis that has killed 15.
The new reports include meningitis in a patient who got another company steroid and fungal infections in two heart transplant patients.


You must be logged in to post comments.

Username:
Password (case sensitive):
Remember Me:

Read Comments

Comments are posted from viewers like you and do not always reflect the views of this station.
  • by Elaine Location: Jackson on Oct 16, 2012 at 05:13 AM
    Probably nothing will ever happen to those that own the pharmaceutical company; they have probably left the country; but their unwillingness to be interviewed by Dr. Sanja Gupta so the public can be better informed is unethical at the very least.
WILX 500 American Road Lansing, MI 48911 517-393-0110
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 174295151 - wilx.com/a?a=174295151
Gray Television, Inc.